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The article Relative and Absolute Risk of Tendon Rup-
ture with Fluoroquinolone and Concomitant Fluoroqui-
nolone/Corticosteroid Therapy: Population-Based Nested 
Case–Control Study, written by Morales DR, Slattery J, 
Pacurariu A, Pinheiro L, McGettigan P, Kurz X, was origi-
nally published Online First without open access. After pub-
lication the authors requested that the article be Open Choice 
to make the article an open access publication. The article is 
forthwith distributed under the terms of the Creative Com-
mons Attribution-NonCommercial 4.0 International License 
(http://creat iveco mmons .org/licen ses/by-nc/4.0/), which per-
mits any noncommercial use, distribution, and reproduction 
in any medium, provided you give appropriate credit to the 
original author(s) and the source, provide a link to the Crea-
tive Commons license, and indicate if changes were made.
The original article has been corrected. 
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution-NonCommercial 4.0 International License 
(http://creativecommons.org/licenses/by-nc/4.0/), which permits any 
noncommercial use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons license, and indicate 
if changes were made.  
The original article can be found online at https ://doi.org/10.1007/
s4026 1-018-0729-y.
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